Markets:

Overview

News

Currencies

International

Treasuries

Foghorn Therapeutics Inc. - Common Stock (NQ:FHTX)

3.809 +0.099 (+2.67%)

Streaming Delayed Price Updated: 2:13 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Foghorn Therapeutics Inc. - Common Stock

< Previous 1 2 3 Next >

This Aardvark Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗

November 07, 2025

Via Benzinga

These stocks are gapping in today's session ↗

November 04, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 11, 2025

Via Benzinga

This PayPal Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Wednesday ↗

April 23, 2025

Via Benzinga

Foghorn Therapeutics: Q4 Earnings Insights ↗

March 07, 2024

Via Benzinga

What 5 Analyst Ratings Have To Say About Foghorn Therapeutics ↗

August 07, 2023

Via Benzinga

Analyst Ratings for Foghorn Therapeutics ↗

June 28, 2023

Via Benzinga

Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

April 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 04, 2025

Via Benzinga

This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

January 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 16, 2024

Via Benzinga

What 6 Analyst Ratings Have To Say About Foghorn Therapeutics ↗

June 08, 2023

Via Benzinga

Analyst Expectations for Foghorn Therapeutics's Future ↗

April 25, 2023

Via Benzinga

Expert Ratings for Foghorn Therapeutics ↗

March 28, 2023

Via Benzinga

Why Foghorn Therapeutics (FHTX) Stock Is Trading Lower ↗

December 16, 2024

Foghorn Therapeutics shares are trading lower by 20.2% during Monday's session. The company announced it will discontinue independent development of its FHD-286 program.

Via Benzinga

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 19, 2024

Via Benzinga

ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday ↗

August 19, 2024

Via Benzinga

FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗

May 06, 2024

FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q4 2023 ↗

March 07, 2024

FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 08, 2024

Via Benzinga

Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher ↗

February 08, 2024

Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.

Via Benzinga

Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 30, 2023

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...

Via Benzinga

Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday ↗

June 29, 2023

Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market...

Via Benzinga

Foghorn Therapeutics Shifts Focus from Development Of Cancer Hopeful with Eye Cancer ↗

June 28, 2023

Foghorn Therapeutics Inc (NASDAQ: FHTX) announced the data from the Phase 1 dose escalation safety study of FHD-286 in

Via Benzinga

Crude Oil Up 1.5%; Philips Shares Jump After Q1 Results ↗

April 24, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 40 points on Monday. The Dow traded up 0.05% to 33,827.42 while the NASDAQ fell 0.33% to 12,032.16....

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

US Stocks Turn Lower; Nasdaq Dips 100 Points ↗

April 24, 2023

U.S. stocks turned lower midway through trading, with the Nasdaq Composite dropping around 100 points on Monday. The Dow traded down 0.19% to 33,744.92 while the NASDAQ fell 0.84% to 11,971. The S&P...

Via Benzinga

More Trouble For Foghorn Therapeutics: After Blood Cancer Trial, FDA Puts Another Cancer Trial On Clinical Hold ↗

April 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 24, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.